Skip to main content

. 1966 Sep 24;2(5516):732–735. doi: 10.1136/bmj.2.5516.732

Clinical observations on the effects of debrisoquine sulphate in patients with high blood-pressure.

D Athanassiadis, W I Cranston, B E Juel-Jensen, D O Oliver

PMCID: PMC1943934 PMID: 5917391

732

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ABRAMS W. B., POCELINKO R., KLAUSNER M., HANAUER L., WHITMAN E. N. CLINICAL PHARMACOLOGICAL STUDIES WITH DEBRISOQUIN SULFATE, A NEW ANTIHYPERTENSIVE AGENT. J New Drugs. 1964 Sep-Oct;4(5):268–283. doi: 10.1002/j.1552-4604.1964.tb00372.x. [DOI] [PubMed] [Google Scholar]
BRYANT J. M., FLETCHER L., Jr, SCHVARTZ N., FERTIG H., QUAN R. B. THE ROLE OF POSTGANGLIONIC SYMPATHETIC BLOCKADE IN ANTIHYPERTENSIVE THERAPY. JAMA. 1965 Sep 20;193:1021–1027. doi: 10.1001/jama.1965.03090120029007. [DOI] [PubMed] [Google Scholar]
LURIA M. H., FREIS E. D. TREATMENT OF HYPERTENSION WITH DEBRISOQUIN SULFATE (DECLINAX). Curr Ther Res Clin Exp. 1965 May;7:289–296. [PubMed] [Google Scholar]
MOE R. A., BATES H. M., PALKOSKI Z. M., BANZIGER R. CARDIOVASCULAR EFFECTS OF 3,4-DIHYDRO-2(1H) ISOQUINOLINE CARBOXAMIDINE (DECLINAX-T.M.). Curr Ther Res Clin Exp. 1964 Apr;6:299–318. [PubMed] [Google Scholar]
RICHARDSON D. W., HONOUR A. J., FENTON G. W., STOTT F. H., PICKERING G. W. VARIATION IN ARTERIAL PRESSURE THROUGHOUT THE DAY AND NIGHT. Clin Sci. 1964 Jun;26:445–460. [PubMed] [Google Scholar]

ACTIONS

RESOURCES